spacer
home > ict > spring 2019 > enhancing the patient experience
PUBLICATIONS
International Clinical Trials

Enhancing the Patient Experience

The opportunities to strengthen patient engagement across all phases of clinical development have never been greater. We can now apply technology in creative ways to collect meaningful data from patients without increasing their burden as trial participants.

At the same time, empowered patients have high expectations of their health-related experiences in general, with clinical trial participation being no exception. As savvy consumers, patients expect technology to be both easy and enjoyable to use. Therefore, study sponsors and CROs should look to take advantage of the latest tools to ensure that a patientís involvement meets their expectations, fits into their daily lives to the greatest extent possible, and is, overall, a rewarding experience.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
James Munz is a product expert who has been solving business problems with cutting edge analytical and technical solutions for close to 20 years. As Vice President of eCOA Product Management, James is responsible for building and executing ERTís market-driven strategy for the eCOA product line. Prior to ERT, he was Vice President of Product at Opera Solutions where he was responsible for the development of a Big Data analytics platform used across supply chain, financial services, marketing, healthcare, and telecommunications industries. Additionally, he led one of the first products to leverage the Amazon Cloud.

Chris Watson PhD is a Product Strategist with 20 yearsí experience in the delivery of business and consumer-based solutions, the last 10 of which have been within the clinical technology industry. He has extensive knowledge of product and software development processes and is responsible for implementing the product strategy for ERTís digital patient business. Chris earned his PhD in Behavioural Neurosciences from the University of Nottingham, UK, and a BSc in pharmacology and toxicology, with honours, from the University of Bradford, UK.
spacer
James Munz
spacer
spacer
spacer
Chris Watson PhD
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Heilbronn/Dortmund August 2019: Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like multiple sclerosis, rheumatoid arthritis or cancer they are considered the future of treatment. Also economically biological drugs are on their way up: The global biopharmaceuticals market is anticipated to reach about 400 billion USD by 2025. Which strategic alignment will help best to fill a successful pipeline?
More info >>

White Papers

Translating Cancer Genomics Into A Personalised Approach For Cancer Patients

PRA Health Sciences (PRA)

Over the past few decades, the approach to prevention, diagnosis and treatment of cancer has radically shifted from organ-based to morphology-based and most recently, to genetics-based. Personalized or precision medicine (tailoring a treatment for a patientís particular disease at a precise time point) is being performed every day at different levels in the clinical setting.
More info >>

 
Industry Events

SCOPE Europe Ė Summit for Clinical Ops Executives Europe

17-18 September 2019, Barcelona, Spain

Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical innovation leaders, clin ops execs, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. The event will feature opening and closing plenary keynote sessions, five conference tracks, interactive breakout discussion groups, and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement